Personen

TOP 5 Publikationen:

1. Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany.Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print].
2. Gründer G, Brand M, Mertens L, Jungaberle H, Kärtner L, Scharf DJ, Spangemacher M, Wolff M. Treatment with psychedelics is psychotherapy: beyond reductionism.Lancet Psychiatry. 2024 11(3):231-236. Epub 2023 Dec 12.
3. Meinhardt M, Güngör C, Skorodumov I, Mertens L, Spanagel R. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.Neuropsychopharmacology. 2020 45(8):1316-1322. Epub 2020 May 5.
4. Spangemacher M, Mertens L, Färber LV, Jungaberle A, Jungaberle H, Gründer G. Psilocybin as a Disease-Modifying Drug—a Salutogenic Approach in Psychiatry.Dtsch Arztebl Int. 2024 121(26):868-874. Epub 2024 Dec 27.
5. Wolff M, Rutrecht H, Mertens L, Meijer AA, Beck J, Pérez S, Gründer G, Dziobek I, Jungaberle H. Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.Psychol Rev. 2025 132(6):1467-1492. Epub 2025 Oct 9.